- Home
- GRRR vs TMCI Comparison
GRRR vs TMCI Comparison
Compare GRRR & TMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRRR
- TMCI
- Stock Information
- Founded
- GRRR 2001
- TMCI 2014
- Country
- GRRR United Kingdom
- TMCI United States
- Employees
- GRRR N/A
- TMCI N/A
- Industry
- GRRR Computer Software: Prepackaged Software
- TMCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- GRRR Technology
- TMCI Health Care
- Exchange
- GRRR Nasdaq
- TMCI Nasdaq
- Market Cap
- GRRR 391.9M
- TMCI 449.2M
- IPO Year
- GRRR N/A
- TMCI 2021
- Fundamental
- Price
- GRRR $18.13
- TMCI $7.22
- Analyst Decision
- GRRR Buy
- TMCI Hold
- Analyst Count
- GRRR 1
- TMCI 5
- Target Price
- GRRR $18.00
- TMCI $8.60
- AVG Volume (30 Days)
- GRRR 1.1M
- TMCI 357.7K
- Earning Date
- GRRR 08-14-2025
- TMCI 11-04-2025
- Dividend Yield
- GRRR N/A
- TMCI N/A
- EPS Growth
- GRRR N/A
- TMCI N/A
- EPS
- GRRR N/A
- TMCI N/A
- Revenue
- GRRR $93,325,178.00
- TMCI $213,751,000.00
- Revenue This Year
- GRRR $38.13
- TMCI $10.63
- Revenue Next Year
- GRRR $28.55
- TMCI $9.44
- P/E Ratio
- GRRR N/A
- TMCI N/A
- Revenue Growth
- GRRR 18.22
- TMCI 7.67
- 52 Week Low
- GRRR $3.16
- TMCI $4.54
- 52 Week High
- GRRR $44.15
- TMCI $10.79
- Technical
- Relative Strength Index (RSI)
- GRRR 55.12
- TMCI 55.39
- Support Level
- GRRR $17.45
- TMCI $6.93
- Resistance Level
- GRRR $18.63
- TMCI $7.48
- Average True Range (ATR)
- GRRR 0.89
- TMCI 0.32
- MACD
- GRRR 0.20
- TMCI -0.06
- Stochastic Oscillator
- GRRR 82.58
- TMCI 34.32
About GRRR Gorilla Technology Group Inc.
Gorilla Technology Group Inc is engaged in providing information, software, and data processing services. It is a provider of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology (OT) security solutions and services. Its reportable segments are video IoT and security convergence and Other segments.
About TMCI Treace Medical Concepts Inc.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.